- Report
- April 2025
- 120 Pages
Global
From €5293EUR$5,950USD£4,598GBP
- Report
- March 2025
- 120 Pages
Global
From €5293EUR$5,950USD£4,598GBP
- Report
- March 2025
- 120 Pages
Global
From €5293EUR$5,950USD£4,598GBP
- Report
- February 2025
- 110 Pages
Global
From €5293EUR$5,950USD£4,598GBP
- Report
- January 2025
- 120 Pages
Global
From €5293EUR$5,950USD£4,598GBP
- Report
- October 2025
- 189 Pages
Global
From €3153EUR$3,545USD£2,740GBP
€3504EUR$3,939USD£3,044GBP
- Report
- October 2025
- 182 Pages
Global
From €3153EUR$3,545USD£2,740GBP
€3504EUR$3,939USD£3,044GBP
- Report
- August 2025
- 199 Pages
Global
From €3153EUR$3,545USD£2,740GBP
€3504EUR$3,939USD£3,044GBP
- Report
- August 2025
- 195 Pages
Global
From €3153EUR$3,545USD£2,740GBP
€3504EUR$3,939USD£3,044GBP
- Report
- August 2025
- 192 Pages
Global
From €3153EUR$3,545USD£2,740GBP
€3504EUR$3,939USD£3,044GBP
- Report
- February 2025
- 135 Pages
Global
From €2215EUR$2,490USD£1,924GBP
- Report
- August 2025
- 217 Pages
Global
From €2224EUR$2,500USD£1,932GBP
- Report
- May 2025
- 219 Pages
Global
From €2224EUR$2,500USD£1,932GBP
- Report
- October 2025
- 414 Pages
Global
From €5204EUR$5,850USD£4,521GBP
- Report
- October 2025
- 154 Pages
Global
From €5204EUR$5,850USD£4,521GBP
- Report
- October 2025
- 200 Pages
Global
From €5204EUR$5,850USD£4,521GBP
- Report
- October 2025
- 179 Pages
Global
From €5204EUR$5,850USD£4,521GBP
- Report
- April 2025
- 175 Pages
Global
From €3994EUR$4,490USD£3,470GBP
- Report
- August 2025
- 190 Pages
Global
From €3153EUR$3,545USD£2,740GBP
€3504EUR$3,939USD£3,044GBP
- Report
- September 2025
- 185 Pages
Global
From €4003EUR$4,500USD£3,478GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more